Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo P Dei Tos

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
The Lancet. Oncology|September 17, 2020
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trialSylvie Bonvalot, Alessandro Gronchi, Cécile Le Péchoux, et al.
JAMA Oncology|February 21, 2020
Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical TrialJavier Martin-Broto, Nadia Hindi, Antonio Lopez-Pousa, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2023
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)Emanuela Palmerini, Marco Gambarotti, Antoine Italiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective StudyBruno Vincenzi, Andrea Napolitano, Marta Fiocco, et al.
JAMA Oncology|June 20, 2024
Current Management of Desmoid Tumors: A ReviewBernd Kasper, Elizabeth H Baldini, Sylvie Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortiumGiacomo G Baldi, Claudia Giani, Silva Ljevar, et al.
JAMA Oncology|May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case SeriesAnna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.
The American Journal of Surgical Pathology|October 28, 2024
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized DiseaseClaudia Giani, Abdulazeez Salawu, Silva Ljevar, et al.
JAMA Oncology|July 9, 2026
Global Consensus on the Management of Primary Localized ChordomaStefano Radaelli, Anna M Frezza, Piero Fossati, et al.
Cancer|April 28, 2021
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entitiesSilvia Stacchiotti, Anna Maria Frezza, Jean-Yves Blay, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
The Lancet. Oncology|September 17, 2020
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trialSylvie Bonvalot, Alessandro Gronchi, Cécile Le Péchoux, et al.
JAMA Oncology|February 21, 2020
Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical TrialJavier Martin-Broto, Nadia Hindi, Antonio Lopez-Pousa, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2023
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)Emanuela Palmerini, Marco Gambarotti, Antoine Italiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective StudyBruno Vincenzi, Andrea Napolitano, Marta Fiocco, et al.
JAMA Oncology|June 20, 2024
Current Management of Desmoid Tumors: A ReviewBernd Kasper, Elizabeth H Baldini, Sylvie Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortiumGiacomo G Baldi, Claudia Giani, Silva Ljevar, et al.
JAMA Oncology|May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case SeriesAnna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.
The American Journal of Surgical Pathology|October 28, 2024
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized DiseaseClaudia Giani, Abdulazeez Salawu, Silva Ljevar, et al.
JAMA Oncology|July 9, 2026
Global Consensus on the Management of Primary Localized ChordomaStefano Radaelli, Anna M Frezza, Piero Fossati, et al.
Cancer|April 28, 2021
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entitiesSilvia Stacchiotti, Anna Maria Frezza, Jean-Yves Blay, et al.
Pageof 10